Кто бы мог подумать! Как мозг заставляет нас делать глупости

¹⁶ Govind A. P. et al. Nicotine-Induced Upregulation of Nicotinic Receptors: Underlying Mechanisms and Relevance to Nicotine Addiction // Biochemical Pharmacology. 2009. Vol. 78. P. 756–765.

¹⁷ Ware J. J. et al. From Men to Mice: CHRNA5/CHRNA3, Smoking Behavior and Disease // Nicotine &Tobacco Research. 2012.

¹⁸ Kaur-Knudsen D. et al. CHRNA3 Genotype, Nicotine Dependence, Lung Function and Disease in the General Population // European Respiratory Journal. 2012. Vol. 40.

P. 1538–1544.

¹⁹ Bierut L. J. et al. Variants in Nicotinic Receptors and Risk for Nicotine Dependence // The American Journal of Psychiatry. 2008. Vol. 165. P. 1163–1171.

²⁰ Sherva R. et al. Association of a Single Nucleotide Polymorphism in Neuronal Acetylcholine Receptor Subunit Alpha 5 (CHRNA5) with Smoking Status and with ‘Pleasurable Buzz’ During Early Experimentation with Smoking // Addiction. September 2008. Vol. 103. No. 9. P. 1544–1552.

²¹ Janes A. C. et al. Association between CHRNA5 Genetic Variation at Rs16969968 and Brain Reactivity to Smoking Images in Nicotine Dependent Women

// Drug and Alcohol Dependence. 1 January 2012. Vol. 120. No. 1–3. P. 7–13.

²² Li M. D. The Genetics of Nicotine Dependence // Current Psychiatry Reports. 2006. Vol. 8. P. 158–164.

²³http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5114a2.htm — оценка опасности курения от Министерства здравоохранения США.

²⁴ Bornman M. S., du Plessis D. J. Smoking and Vascular Impotence. A Reason for Concern // South African Medical Journal. 13 September 1986. Vol. 70. No. 6. P. 329–30.

²⁵ Mamede M. et al.Temporal Change in Human Nicotinic Acetylcholine Receptor After Smoking Cessation: 5IA SPECT Study // Journal of Nuclear Medicine. 2007. Vol. 48. P. 1829–1835.

²⁶ Taylor D. H. et al. Benefits of Smoking Cessation for Longevity

// The American Journal of Public Health. June 2002. Vol. 92. No. 6. P. 990–996.

²⁷ Kendall S. B. Preference for Intermittent Reinforcement // Journal of the Experimental Analysis of Behavior. May 1974. Vol. 21. No. 3. P. 463–473.

²⁸ Jorenby D. E. et al. Efficacy of Varenicline, an α4β² Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation. A Randomized Controlled Trial // JAMA. 2006. Vol. 296. No. 1. P. 56–63.

²⁹ Moore D. et al. Effectiveness and Safety of Nicotine Replacement Therapy Assisted Reduction to Stop Smoking: Systematic Review and Meta-Analysis // British Medical Journal. 2009. Vol. 338.

³⁰ Cornuz J. et al. A Vaccine Against Nicotine for Smoking Cessation: A Randomized Controlled Trial

// PLoS ONE 3 (6): e2547.

³¹ Hicks M. J. et al. AAV — Directed Persistent Expression of a Gene Encoding Anti-Nicotine Antibody for Smoking Cessation // Science Translational Medicine. 27 June 2012.

Глава 3. Был пьян, ничего не помню!

¹ Бенеке М. Прикольная наука. Из тайных архивов Шнобелевской премии: в 2 кн. / пер. с нем. А. Шкуридиной. — М.: Книжный Клуб 36.6, 2011.

² Hamermesh D. S., Biddle J. E. Beauty and the Labor Market // American Economic Review. December 1994. Vol. 84. Р. 1174–1194.

³ Auld M. C. Smoking, Drinking, and Income // The Journal of Human Resources. Spring 2005. Vol. XL. No. 2. Р. 505–518.

⁴ Sarviharju M. et al.Survival of AA and ANA Rats During Lifelong Ethanol Exposure // Alcoholism: Clinical and Experimental Research. January 2004. Vol. 28. No. 1. P. 93–97.